A. Pessi

发表

Capturing a Fusion Intermediate of Influenza Hemagglutinin with a Cholesterol-conjugated Peptide, a New Antiviral Strategy for Influenza Virus*

Kelly K. Lee, L. Gui, M. Porotto, 2011, The Journal of Biological Chemistry.

Universal Influenza B Vaccine Based on the Maturational Cleavage Site of the Hemagglutinin Precursor

Emily P. Wen, Colleen E. Price, R. Cortese, 2005, Journal of Virology.

Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.

Michael D. Miller, W. Schleif, R. Geleziunas, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Probing the tertiary structure of proteins by limited proteolysis and mass spectrometry: The case of minibody

Anna Tramontano, Gennaro Marino, Francesca Zappacosta, 1996, Protein science : a publication of the Protein Society.

Activity of purified hepatitis C virus protease NS3 on peptide substrates

A. Urbani, R. De Francesco, L. Tomei, 1996, Journal of virology.

Membrane protein 4F2/CD98 is a cell surface receptor involved in the internalization and trafficking of human β-Defensin 3 in epithelial cells.

A. Zagari, F. Salvatore, D. Sarnataro, 2015, Chemistry & biology.

Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library

A. Palani, L. Tomei, S. Mumick, 2018, Scientific Reports.

A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity.

A. Pocai, A. Pessi, Alessia Santoprete, 2013, Bioorganic & medicinal chemistry.

DPP‐IV‐resistant, long‐acting oxyntomodulin derivatives

A. Pocai, F. Bonelli, A. Pessi, 2011, Journal of peptide science : an official publication of the European Peptide Society.

2‐D Difference in gel electrophoresis combined with Pro‐Q Diamond staining: A successful approach for the identification of kinase/phosphatase targets

L. Tomei, Laura Orsatti, A. Pessi, 2009, Electrophoresis.

Rapid Screening for Entry Inhibitors of Highly Pathogenic Viruses under Low-Level Biocontainment

M. Whitt, T. Briese, M. Porotto, 2012, PloS one.

Viral Entry Inhibitors Targeted to the Membrane Site of Action

Laura M. Palermo, R. Cortese, L. M. Palermo, 2010, Journal of Virology.

A Multimeric Synthetic Peptide Combinatorial Library.

G. Ciliberto, C. Toniatti, S. Altamura, 1994, Peptide research.

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

Michael E. Lassman, N. Thornberry, Gaochao Zhou, 2009, Diabetes.

1H‐nmr studies of synthetic polypeptide models of Plasmodium falciparum circumsporozoite protein tandemly repeated sequence

A. Pessi, A. Verdini, G. Esposito, 1989, Biopolymers.

Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus.

R. Cortese, R. Bazzo, U. Koch, 2002, Biochemistry.

The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.

P. Lambert, A. Pessi, J. Merino, 1986, Journal of immunology.

ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose.

F. Bonelli, B. Hubbard, A. Pessi, 2010, Bioorganic & medicinal chemistry.

Adjuvant Systemic Therapies in Patients with Colorectal Cancer: An Audit on Clinical Practice in Italy

S. Barni, R. Labianca, G. Luporini, 2005, Tumori.

A loop-mimetic inhibitor of the HCV-NS3 protease derived from a minibody.

R. Cortese, R. De Francesco, A. Pessi, 1999, Protein engineering.

Infection of Primary Neurons Mediated by Nipah Virus Envelope Proteins: Role of Host Target Cells in Antiviral Action

M. Porotto, A. Pessi, A. Talekar, 2011, Journal of Virology.

Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity

G. Ciliberto, S. Costantini, A. Budillon, 2019, Scientific Reports.

Prime Site Binding Inhibitors of the Hepatitis C Virus NS3/4A Serine Protease

R. Cortese, R. Bazzo, S. Altamura, 2001 .

An improved solid-phase synthesis of resonance energy transfer fluorescent peptides and depsipeptides employing the EDANS/DABCYL donor-acceptor pair

M. Taliani, A. Pessi, E. Bianchi, 1997, Letters in Peptide Science.

Novel potent apoA-I peptide mimetics that stimulate cholesterol efflux and pre-beta particle formation in vitro.

A. Pessi, E. Bianchi, C. Burton, 2010, Bioorganic & medicinal chemistry letters.

The effect of prime‐site occupancy on the hepatitis C virus NS3 protease structure

P. Pucci, S. Orrù, A. Pessi, 2002, Protein science : a publication of the Protein Society.

Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation*

R. Cortese, A. Nicosia, A. Tarr, 2014, The Journal of Biological Chemistry.

A new method for chemoselective conjugation of unprotected peptides to dauno- and doxorubicin.

M. Taliani, A. Pessi, P. Ingallinella, 2001, Bioorganic & medicinal chemistry letters.

Synthesis of a functionalized high affinity mannose receptor ligand and its application in the construction of peptide‐, polyamide‐ and PNA‐conjugates

A. Pessi, E. Bianchi, P. Ingallinella, 2003, Journal of peptide science : an official publication of the European Peptide Society.

A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates.

A. Urbani, R. Francesco, R. De Francesco, 1996, Analytical biochemistry.

Surface topology of Minibody by selective chemical modifications and mass spectrometry

A. Tramontano, A. Scaloni, G. Marino, 1997, Protein science : a publication of the Protein Society.

Mycobacterial heat‐shock proteins as carrier molecules

J. Louis, P. Lambert, A. Pessi, 1991, European journal of immunology.

Mechanisms of hepatitis C virus NS3 proteinase inhibitors

R. Francesco, R. De Francesco, A. Pessi, 1999, Journal of viral hepatitis.

The bat influenza H17N10 can be neutralized by broadly-neutralizing monoclonal antibodies and its neuraminidase can facilitate viral egress

G. Carnell, K. Grehan, S. Scott, 2018, medRxiv.

The Glucagon Receptor Is Involved in Mediating the Body Weight-Lowering Effects of Oxyntomodulin

A. Pocai, J. Mu, A. Pessi, 2012, Obesity.

Solid Phase Synthesis of Peptide C-Terminal Thioesters by Fmoc/t-Bu Chemistry

A. Pessi, E. Bianchi, R. Ingenito, 1999 .

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.

D. Ribatti, V. Castronovo, Laura Orsatti, 2007, Blood.

A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp 41 epitope

D. Hazuda, R. Cortese, G. Ciliberto, 2005 .

A high-throughput radiometric assay for hepatitis C virus NS3 protease.

A. Urbani, R. De Francesco, S. Altamura, 1999, Analytical biochemistry.

Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes.

M. Erion, A. Palani, A. Pessi, 2022, ACS medicinal chemistry letters.

Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41.

J. Condra, A. Pessi, J. Joyce, 2008, AIDS research and human retroviruses.

Lack of H‐2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide

D. Valmori, P. Migliorini, P. Lambert, 1991, European journal of immunology.

A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H‐2 haplotypes

F. Bonelli, J. Louis, P. Lambert, 1990, European journal of immunology.

Engineering and Chemical Synthesis of a Transmembrane Protein: The HCV Protease Cofactor Protein NS4A

A. Pessi, E. Bianchi, R. J. Simon, 1999 .

Induction of Cross-reactive Humoral Immune Response by Immunization with Mimotopes of the Hypervariable Region 1 of the Hepatitis C Virus

A. Tramontano, A. Folgori, R. Tafi, 2001, International reviews of immunology.

Use of a conformationally restricted secondary structural element to display peptide libraries: a two-stranded alpha-helical coiled-coil stabilized by lactam bridges.

R. Hodges, A. Pessi, E. Bianchi, 1996, Journal of molecular biology.

Detection of human antibodies against Plasmodium falciparum sporozoites using synthetic peptides

J. Verhave, P. Lambert, A. Pessi, 1987, Journal of clinical microbiology.

Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants.

L. Rénia, J. Verhave, J. Louis, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice.

F. Bonelli, A. Pessi, G. Del Giudice, 1986, Journal of immunology.

Synthetic peptide vaccines: the quest to develop peptide vaccines for influenza, HIV and Alzheimer's disease.

G. Ciliberto, J. Shiver, Xiao-ping Liang, 2009, Advances in experimental medicine and biology.

Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency

John P. Moore, T. Ketas, F. Bonelli, 2009, Proceedings of the National Academy of Sciences.

A practical approach to the synthesis of hairpin polyamide-peptide conjugates through the use of a safety-catch linker.

A. Pessi, E. Bianchi, P. Ingallinella, 2002, Bioorganic & medicinal chemistry letters.

Chemical synthesis of a designed β-protein through the flow-polyamide method

A. Tramontano, A. Pessi, E. Bianchi, 2009 .

Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure.

N. Santos, M. T. Augusto, M. Porotto, 2014, The Journal of antimicrobial chemotherapy.

Fusicoccin binding sites in subcellular preparations of spinach leaves

A. Pessi, A. Ballio, R. Federico, 1980 .

Design of a small protein as a potential source of selectable peptide sequences of known structure

A. Tramontano, A. Pessi, E. Bianchi, 1995 .

7 Conformationally Defined Peptide Libraries on Phage: Selectable Templates for the Design of Pharmacological Agents

F. Felici, R. Cortese, A. Pessi, 1996 .

Product inhibition of the hepatitis C virus NS3 protease.

R. Cortese, U. Koch, A. Urbani, 1998, Biochemistry.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, A. Hauschild, J. Malvehy, 2016, Journal of Translational Medicine.

A designed metal-binding protein with a novel fold

Anna Tramontano, A. Tramontano, A. Crameri, 1993, Nature.

Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells

G. Botti, P. Ascierto, G. Ciliberto, 2017, Journal of experimental & clinical cancer research : CR.

Selection of Potent Inhibitors of Farnesyl-protein Transferase from a Synthetic Tetrapeptide Combinatorial Library*

R. Cortese, J. Gibbs, A. Pessi, 1996, The Journal of Biological Chemistry.

A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope.

Gennaro Ciliberto, Peter S Kim, Simon Lennard, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Anti‐circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka

C. Mendis, A. Gamage-Mendis, K. Mendis, 1992, Parasite immunology.

Cholesterol‐conjugated peptide antivirals: a path to a rapid response to emerging viral diseases†

A. Pessi, 2014, Journal of peptide science : an official publication of the European Peptide Society.

Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion.

Gennaro Ciliberto, R. Cortese, G. Ciliberto, 2003, Journal of molecular biology.

Use of synthetic peptides in the study of the antibody response to Plasmodium vivax sporozoites.

K. Mendis, R. Carter, P. Lambert, 1990, The American journal of tropical medicine and hygiene.

Characterization of murine monoclonal antibodies against a repetitive synthetic peptide from the circumsporozoite protein of the human malaria parasite, Plasmodium falciparum.

L. Rénia, T. Ponnudurai, J. Louis, 1991, Molecular immunology.

A rapid inhibition micro ELISA for detecting antibodies to Plasmodium falciparum sporozoites in human blood.

A. Pessi, A. Verdini, A. Bernardi, 1990, Journal of immunoassay.

Primary and Secondary Responses to (NANP) Peptides by Plasmodium falciparum Sporozoites in Various Strains of Mice

G. Grau, P. Lambert, A. Pessi, 1989, Scandinavian journal of immunology.

Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.

F. Bonelli, A. Pessi, C. Chizzolini, 1988, Immunology.

Inhibition of Nipah Virus Infection In Vivo: Targeting an Early Stage of Paramyxovirus Fusion Activation during Viral Entry

Min Lu, Heinz Feldmann, Laura M. Palermo, 2010, PLoS pathogens.

Fatal Measles Virus Infection Prevented by Brain-Penetrant Fusion Inhibitors

M. Porotto, A. Pessi, A. Talekar, 2013, Journal of Virology.

Spring-Loaded Model Revisited: Paramyxovirus Fusion Requires Engagement of a Receptor Binding Protein beyond Initial Triggering of the Fusion Protein

J. Yee, M. Porotto, A. Pessi, 2011, Journal of Virology.

Lipophilicity is a key factor to increase the antiviral activity of HIV neutralizing antibodies.

N. Santos, M. T. Augusto, A. Pessi, 2016, Colloids and surfaces. B, Biointerfaces.

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas

G. Botti, G. Botti, G. Ciliberto, 2017, Scientific Reports.

Conformation of a novel tetrapeptide inhibitor NH2-D-Trp-D-Met-Phe(pCl)-Gla-NH2 bound to farnesyl-protein transferase.

V. Garsky, A. Pessi, M. Bogusky, 1999, The journal of peptide research : official journal of the American Peptide Society.

A first-in-human study of the novel HIV-fusion inhibitor C34-PEG4-Chol

R. Cortese, A. Nicosia, V. Libri, 2017, Scientific Reports.

Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filaments

D. Neill, A. Pessi, E. Bianchi, 1998, FEBS letters.

Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin

R. Cortese, A. Nicosia, J. Ball, 2015, Journal of peptide science : an official publication of the European Peptide Society.

Progress towards the development of a HIV-1 gp41-directed vaccine.

G. McGaughey, R. Freidinger, J. Shiver, 2004, Current HIV research.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, David C. Smith, A. Hauschild, 2016, Journal of Translational Medicine.

Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial tool

F. Salvatore, M. Galdiero, M. Cantisani, 2015, International journal of nanomedicine.

PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes.

A. Peier, A. Pocai, R. Laufer, 2012, Bioorganic & medicinal chemistry.

Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products.

R. Cortese, R. De Francesco, S. Altamura, 1998, Biochemistry.

Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates

D. Montefiori, J. Shiver, A. Finnefrock, 2010, Proceedings of the National Academy of Sciences.

A personal account of the role of peptide research in drug discovery: the case of hepatitis C 1

A. Pessi, 2001, Journal of peptide science : an official publication of the European Peptide Society.

The proteinases encoded by hepatitis C virus as therapeutic targets

U. Koch, R. Francesco, A. Pessi, 2000 .

Development of a neuromedin U–human serum albumin conjugate as a long‐acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide

A. Peier, A. Pocai, R. Laufer, 2014, Journal of peptide science : an official publication of the European Peptide Society.

Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein

A. Carfi, A. Pessi, E. Bianchi, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.

A. Carfi, D. Eckert, A. Pessi, 2004, Proceedings of the National Academy of Sciences of the United States of America.

A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity

R. Cortese, T. Ketas, M. Porotto, 2012, PloS one.

Generation and screening of solution-phase synthetic peptide combinatorial libraries

R. Cortese, J. Gibbs, A. Pessi, 1999 .

Substrate Specificity of the Hepatitis C Virus Serine Protease NS3*

A Tramontano, A. Tramontano, A. Urbani, 1997, The Journal of Biological Chemistry.

An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule

J. Ball, A. Carotenuto, F. Salvatore, 2015, Scientific Reports.

Complex formation between the hepatitis C virus serine protease and a synthetic NS4A cofactor peptide.

A. Urbani, R. De Francesco, A. Pessi, 1997, Biochemistry.

E. Delaporte, A. Pessi, C. Chizzolini, 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Analysis of in vitro and in vivo products of the TMV 30kDa open reading frame using antisera raised against a synthetic peptide

P. Kiberstis, T. Hunter, R. Jackson, 1983, FEBS letters.

Inhibiting viral proteases: challenges and opportunities.

A. Pessi, E. Bianchi, 2002, Biopolymers.

Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies.

R. Cortese, R. Bazzo, U. Koch, 1999, Journal of molecular biology.

Reduced antibody response to the repetitive sequence of the Plasmodium falciparum circumsporozoite protein in mice infected with Plasmodium yoelii blood forms

D. Grillot, P. Lambert, A. Pessi, 2004, Medical Microbiology and Immunology.

High-performance liquid chromtography of naturally occuring benzoxazolinones

A. Pessi, D. Scalorbi, 1979 .

Ligands for κ-Opioid and ORL1 Receptors Identified from a Conformationally Constrained Peptide Combinatorial Library*

F. Simonin, B. Kieffer, A. Pessi, 1999, The Journal of Biological Chemistry.

The Hepatitis C Virus NS3 Proteinase: Structure and Function of a Zinc-Containing Serine Proteinase

R. De Francesco, A. Pessi, C. Steinkühler, 1998, Antiviral therapy.

A novel smaller β‐defensin‐derived peptide is active against multidrug‐resistant bacterial strains

F. Carbone, G. Matarese, F. Salvatore, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Natural antibodies against three distinct and defined antigens of Plasmodium falciparum in residents of a mesoendemic area in Gabon.

A. Pessi, C. Chizzolini, G. Del Giudice, 1988, The American journal of tropical medicine and hygiene.

Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria.

M. Tanner, K. Mendis, P. Lambert, 1990, Bulletin of the World Health Organization.

Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.

P. Lambert, A. Pessi, G. Del Giudice, 1987, The American journal of tropical medicine and hygiene.

Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library

A. Palani, L. Tomei, A. Pessi, 2018, Scientific Reports.

Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes.

A. Tramontano, A. Folgori, R. Tafi, 2001, Molecular immunology.

Host defense peptide‐derived privileged scaffolds for anti‐infective drug discovery

F. Salvatore, D. Sarnataro, A. Pessi, 2017, Journal of peptide science : an official publication of the European Peptide Society.

Structural basis for HIV-1 neutralization by a gp41 fusion intermediate–directed antibody

M. Luftig, R. Geleziunas, A. Carfi, 2006, Nature Structural &Molecular Biology.

Measurement of homonuclear three-bond J(HNHα) coupling constants in unlabeled peptides complexed with labeled proteins: Application to a decapeptide inhibitor bound to the proteinase domain of the NS3 protein of hepatitis C virus (HCV)

R. Bazzo, U. Koch, R. De Francesco, 2001, Journal of biomolecular NMR.

Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells

G. Botti, P. Ascierto, G. Ciliberto, 2017, Journal of experimental & clinical cancer research : CR.

Solid phase synthesis of retro-inverso peptide analogues. Synthesis and biological activity of the partially modified retro-inverso analogue of the bradykinin potentiating peptide BPP9a [gLys6, (RS)-mPhe7, Ala8] BPP9a.

F. Bonelli, A. Pessi, A. Verdini, 2009, International journal of peptide & protein research.

Solid phase synthesis of retro-inverso peptide analogues. Synthesis of a partially modified retro-inverso analogue of substance P, [Glp6, gPhe8, mGly9] SP6–11[gPhe =–NHCH(CH2Ph)NH–,mGly =–OCCH2CO–]

A. Pessi, A. Verdini, G. Viscomi, 1983 .

Probing the Active Site of the Hepatitis C Virus Serine Protease by Fluorescence Resonance Energy Transfer*

A. Urbani, R. De Francesco, F. Narjes, 2000, The Journal of Biological Chemistry.

Engineering and chemical synthesis of the HCV protease transmembrane protein cofactor NS4A

A. Pessi, E. Bianchi, R. J. Simon, 2002 .

A peptide vaccine based on retro-inverso beta-amyloid sequences fails to elicit a cross-reactive immune response.

Xiao-ping Liang, A. Pessi, E. Bianchi, 2009, Advances in experimental medicine and biology.

Application of the continuous-flow polyamide method to the solid-phase synthesis of a multiple antigen peptide (MAP) based on the sequence of a malaria epitope

F. Bonelli, A. Pessi, E. Bianchi, 1990 .

Substrate specificity and mechanism of activation of hepatitis C virus protease

A. Urbani, R. Francesco, A. Pessi, 2002 .

Intraerythrocytic administration of a synthetic Plasmodium antigen elicits antibody response in mice, without carrier molecules or adjuvants.

A. Santroni, A. Pessi, S. Lombardi, 1990, International Journal of Parasitology.

Malaria transmission and develoment of anti-sporozoite antibodies in a rural african community

M. Tanner, P. Lambert, A. Pessi, 1986 .

Optimization of the P'-region of peptide inhibitors of hepatitis C virus NS3/4A protease.

U. Koch, S. Altamura, A. Pessi, 2000, Biochemistry.

Synthetic peptides for Plasmodium vivax malaria sero-epidemiology. Application of Fmoc-polyamide and displacement chromatography.

A. Pessi, E. Bianchi, G. Del Giudice, 2009, International journal of peptide and protein research.

Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay.

G. Ciliberto, J. Shiver, W. Schleif, 2004, Journal of immunological methods.

Further engineering of a designed protein, the minibody: from an insoluble to a soluble molecule

A. Tramontano, R. Bazzo, A. Pessi, 1994 .

Antibodies to Plasmodium falciparum sporozoites following a malarial outbreak in a non-endemic area of Sri Lanka.

J. Peiris, A. Pessi, G. Del Giudice, 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Conformational changes in human hepatitis C virus NS3 protease upon binding of product-based inhibitors.

U. Koch, P. Pucci, S. Orrù, 1999, Biochemistry.

Structural Studies of the Complex Between Decapeptide Inhibitors and the Serine Protease NS3/4A of Hepatitis C Virus

P. Pucci, A. Pessi, E. Bianchi, 2001 .

Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer: a critical review of comparative studies.

M. Pirovano, R. Labianca, G. Luporini, 1996, European journal of cancer.

Sporozoite antibodies and malaria in children in a rural area of The Gambia.

R. Snow, S. Lindsay, B. Greenwood, 1989, Annals of tropical medicine and parasitology.

Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.

S. Radoshitzky, J. Shiver, S. Bavari, 2019, Antiviral research.

A first-in-human study of the novel HIV-fusion inhibitor C34-PEG4-Chol

R. Cortese, A. Nicosia, V. Libri, 2017, Scientific Reports.

High-resolution solution structure of two members of a conformationally homogeneous combinatorial peptide library based on the classical zinc-finger motif

R. Bazzo, A. Pessi, E. Bianchi, 1996, Journal of biomolecular NMR.

Spring-Loaded Model Revisited: Paramyxovirus Fusion Requires Engagement of a Receptor Binding Protein beyond Initial Triggering of the Fusion Protein

J. Yee, M. Porotto, A. Pessi, 2011, Journal of Virology.

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.

D. Ribatti, V. Castronovo, Laura Orsatti, 2007, Blood.

Editorial: peptide-based strategies for protease inhibition.

A. Pessi, 2002, Biopolymers.

A personal account of the role of peptide research in drug discovery: the case of hepatitis C 1

A. Pessi, 2001, Journal of peptide science : an official publication of the European Peptide Society.

ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum.

F. Felici, R. Cortese, P. Monaci, 2001, European journal of biochemistry.

Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41

J. Condra, A. Finnefrock, M. Luftig, 2009, mAbs.